Vascular Disruptive Agents for the Treatment of Cancer - Meyer, Tim.; SpringerLink (Online service) (New York, NY : Springer New York : Imprint: Springer, 2010)
Development of Vascular Disrupting Agents -- Development of Vascular Disrupting Agents -- Pre-Clinical Development -- The Discovery and Characterisation of Tumour Endothelial Markers -- The Use of Animal Models in the Assessment of Tumour Vascular Disrupting Agents (VDAs) -- Combination Therapy with Chemotherapy and VDAs -- Lessons from Animal Imaging in Preclinical Models -- Combining Antiangiogenic Drugs with Vascular Disrupting Agents Rationale and Mechanisms of Action -- Imaging in the Development of Vascular Disruptive Agents -- MRI to Assess Vascular Disruptive Agents -- Contrast Ultrasound in Imaging Tumor Angiogenesis -- Clinical Development -- The Clinical Development of Tubulin Binding Vascular Disrupting Agents -- ASA404 (DMXAA): New Concepts in Tumour Vascular Targeting Therapy -- Vascular Disruptive Agents in Combination with Radiotherapy.
Keywords: Cancer research; Pharmacology; Cancer Research; Pharmacology/Toxicology.